Detailed answers about J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD, including incorporation, status, business activity, and accounts information.
When was J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD founded?
J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD was officially incorporated on 6 February 2023 and is registered under company number 14641149. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD?
J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD do?
J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD operates in the following sector: 47730 - Dispensing chemist in specialised stores. This provides insight into the company's primary business activity and industry focus.
What is J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD's registered address?
The registered office address of J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD is 17 CROMWELL AVENUE, GATLEY, CHEADLE, ENGLAND, SK8 4BS. This is the official address filed with Companies House for legal and statutory correspondence.
Is J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD financially stable?
The most recent accounts for J3 CONSULTING AND PHARMACEUTICAL SERVICES LTD were made up to 28 February 2025, filed as MICRO ENTITY. Next accounts are due by 30 November 2026.